Safety and Pharmacokinetics Study of FBF001

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Conditions
Avian Influenza
Interventions
BIOLOGICAL

FBF001

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Fab'entech

INDUSTRY

NCT02295813 - Safety and Pharmacokinetics Study of FBF001 | Biotech Hunter | Biotech Hunter